This session examines disorders caused by abnormal immune activation against the body’s own tissues or by dysregulated innate inflammatory pathways. It covers disease mechanisms, genetic and environmental influences, clinical presentation, diagnosis, biomarkers, treatment response, disease monitoring, and the long-term impact of autoimmune and autoinflammatory conditions.
Abstract Scope and Participation
Researchers and clinicians may submit basic, clinical, translational, or population-based studies, along with case reports, reviews, and therapeutic evaluations. The session encourages participation from immunologists, rheumatologists, physicians, geneticists, laboratory researchers, pharmaceutical professionals, and multidisciplinary teams managing immune-mediated inflammatory diseases.
Submit your abstract Today
Title : Antibody proteases as translational biomarkers, targets, and biocatalysts of the next generation step as applicable for design driven precision medical practice
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through biodesign inspired and immunology related translational applications to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation